Morphine (1 mg/mL)
Lack of assurance of sterility
982 recalls · Class II, newest first
Lack of assurance of sterility
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
Presence of Particulate Matter: Crystalline particles were noticed by manufacturer at the 24 month clarity testing.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Marketed Without an Approved NDA/ANDA: Undeclared Sibutramine
Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle
CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.